Warning: Cannot modify header information - headers already sent by (output started at /nfs/aesop1/hw00/d51/cfrtc/index.php:1) in /nfs/aesop1/hw00/d51/cfrtc/wp-includes/feed-rss2.php on line 8 Cystic Fibrosis Research and Translation Center (CFRTC)
https://depts.washington.edu/cfrtc
Wed, 16 Apr 2025 22:26:16 +0000en-US
hourly
1 https://wordpress.org/?v=6.3.13Mike Welsh and Paul Negulescu announced as 2025 Canada Gairdner Award recipients
https://www.gairdner.org/resource-hub/2025-canada-gairdner-award-winners#new_tab
Wed, 16 Apr 2025 21:13:32 +0000https://depts.washington.edu/cfrtc/?p=3248For pioneering research into the cellular and molecular mechanisms underlying the genetic disease cystic fibrosis.
…
]]>Effects of Therapeutic Antibiotic Exposure on the Oropharyngeal and Fecal Microbiota in Infants with Cystic Fibrosis. Hayden HS, et al. Pediatr Pulmonal. 2025 Mar. PMID: 40042126
https://pubmed.ncbi.nlm.nih.gov/40042126/#new_tab
Mon, 28 Oct 2024 17:22:46 +0000https://depts.washington.edu/cfrtc/?p=2963Cystic Fibrosis Microbiological Outcomes Advancement Core (MOAC)
https://depts.washington.edu/cfrtc/cystic-fibrosis-microbiological-outcomes-advancement-core-moac/
Sat, 26 Oct 2024 01:34:25 +0000https://depts.washington.edu/cfrtc/?p=2877
This NRC develops and provides special and clinically relevant microbiological tests and resources for CF research and therapeutics development, including clinical specimens and microbial isolates, uncommon culture media and conditions, and molecular (DNA-based) microbiological identification and quantitation. This core will also serve as a repository of the specimens and isolates collected by CF studies; as a facility that can perform existing, nonstandard tests (such as sputum binding and in vitro susceptibility testing for new candidate treatments); and as a laboratory that develops new approaches and resources and performs new tests, such as DNA-based analyses.…]]>Bonnie Ramsey announced as APS 2025 John Howland Award Recipient
https://www.aps1888.org/2025-john-howland-award-recipient/#new_tab
Thu, 09 Dec 2021 22:25:00 +0000http://depts.washington.edu/cfrtc/?p=2275Distinguished pediatrics leader is recognized for her significant contributions to advancing child health and the profession of pediatrics.
…
]]>Trikafta approved for children ages 6 to 11 with certain mutations
https://depts.washington.edu/cfrtc/triple-therapy-6-11/
Wed, 09 Jun 2021 17:23:57 +0000http://depts.washington.edu/cfrtc/?p=2377NEW – CF Foundation Spring 2020 RFAs
https://depts.washington.edu/cfrtc/new-cff-spring-2020-rfas/
Sun, 29 Mar 2020 19:17:58 +0000http://depts.washington.edu/cfrtc/?p=2060CF Foundation Celebrates FDA Approval of Triple Combination
https://depts.washington.edu/cfrtc/triple-therapy/
Sat, 07 Dec 2019 03:41:08 +0000http://depts.washington.edu/cfrtc/?p=2008Bonnie Ramsey awarded 2018 Warren Alpert Foundation Prize
https://depts.washington.edu/cfrtc/bonnie-ramsey-awarded-warren-alpert-foundation-prize/
Thu, 26 Jul 2018 00:34:59 +0000http://depts.washington.edu/cfrtc/?p=1634Dr. Lucas Hoffman awarded Robert B. Mellins, MD, Outstanding Achievement Endowed Award
https://depts.washington.edu/cfrtc/dr_lucas_hoffman_awarded_mellins/
Wed, 26 Apr 2017 20:35:03 +0000http://depts.washington.edu/cfrtc/?p=1028A new funding opportunity from CFF: Advancing Gene Editing Technologies and Tools for Cystic Fibrosis
https://depts.washington.edu/cfrtc/cf-ria-2/
Tue, 27 Nov 2018 00:08:48 +0000http://depts.washington.edu/cfrtc/?p=1749